UK small-cap RNS · 5 Oct 2026
Every announcement of UK small & mid caps under £2bn. The ones that started or moved a situation are marked – a click opens it.
Key = all announcements except routine filings (voting rights, buybacks, holdings, director forms), plus the ones that are part of a situation. Not investment advice.
| Time | Company | Mcap ↕ | Type | Announcement | |
|---|---|---|---|---|---|
| 13:00 | EnSilica ENSI | £101m | Transformational contract / build-out | Final Results
The following announcement replaces the "Final Results" announcement released on 5 October 2026 at 07:00 under RNS number 5781X. |
|
| 09:00 | Milton Capital MII | £0.5m | Results | Unaudited interim results to 31 July 2026
Unaudited interim results for the period ended 31 July 2026 |
|
| 07:00 | Genflow Biosciences GENF | £11m | Results | Presentation of Interim Results
Presentation of Interim Results from SLAB Canine Study at the Animal Longevity Summit |
|
| 07:00 | EnSilica ENSI | £101m | Transformational contract / build-out | Final Results
Record FY26 demonstrated the scalability of EnSilica’s business model |